Financial Assets at Fair Value Through Other Comprehensive Income (Tables)
|
12 Months Ended |
Dec. 31, 2024 |
Financial Assets at Fair Value Through Other Comprehensive Income [Abstract] |
|
Schedule of Financial Asset |
As of December 31, 2024 and 2023, financial
assets are detailed as follows:
| |
2024 | | |
2023 | |
| |
MCh$ | | |
MCh$ | |
Debt Financial Instruments | |
| 2,088,345 | | |
| 3,786,525 | |
Equity Instruments | |
| 9,492 | | |
| 11,912 | |
Total | |
| 2,097,837 | | |
| 3,798,437 | |
|
Schedule of Debt Financial Instruments |
As of December
31, 2024 and 2023 the detail of debt financial instruments is as follows:
| |
2024 | | |
2023 | |
| |
MCh$ | | |
MCh$ | |
Instruments issued by the Chilean Government and Central Bank of Chile | |
| | |
| |
Debt financial instruments from the Central Bank of Chile | |
| — | | |
| 473,642 | |
Bonds and Promissory notes from the Chilean Government | |
| 660,321 | | |
| 1,362,510 | |
Other fiscal debt financial instruments | |
| 456 | | |
| 1,500 | |
| |
| | | |
| | |
Other Instruments Issued in Chile | |
| | | |
| | |
Debt financial instruments from other domestic banks | |
| 1,321,030 | | |
| 1,681,744 | |
Bonds and trade effects from domestic companies | |
| 54,600 | | |
| 59,921 | |
Other debt financial instruments issued in the country | |
| — | | |
| — | |
| |
| | | |
| | |
Instruments Issued Abroad | |
| | | |
| | |
Financial instruments from foreign Central Banks | |
| — | | |
| — | |
Financial instruments from foreign governments and fiscal entities | |
| 48,883 | | |
| 43,294 | |
Debt financial instruments from other foreign banks | |
| — | | |
| 163,914 | |
Bonds and trade effects from foreign companies | |
| 3,055 | | |
| — | |
Other debt financial instruments issued abroad | |
| — | | |
| — | |
Total | |
| 2,088,345 | | |
| 3,786,525 | |
|
Schedule of Credit Ratings of the Issuers of Debt Instruments |
The credit ratings of the issuers of debt instruments as of December 31, 2024 and 2023, are as follows:
|
|
As of December 31, 2024 |
|
|
As of December 31, 2023 |
|
|
|
Stage 1
Individual |
|
|
Stage 2
Individual |
|
|
Stage 3
Individual |
|
|
Total
Individual |
|
|
Stage 1
Individual |
|
|
Stage 2
Individual |
|
|
Stage 3
Individual |
|
|
Total
Individual |
|
|
|
MCh$ |
|
|
MCh$ |
|
|
MCh$ |
|
|
MCh$ |
|
|
MCh$ |
|
|
MCh$ |
|
|
MCh$ |
|
|
MCh$ |
|
Debt Instrument |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Investment grade |
|
|
2,088,345 |
|
|
|
— |
|
|
|
— |
|
|
|
2,088,345 |
|
|
|
3,786,525 |
|
|
|
— |
|
|
|
— |
|
|
|
3,786,525 |
|
Non-investment grade |
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
Without rating |
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
Total |
|
|
2,088,345 |
|
|
|
— |
|
|
|
— |
|
|
|
2,088,345 |
|
|
|
3,786,525 |
|
|
|
— |
|
|
|
— |
|
|
|
3,786,525 |
|
|
Schedule of Changes in Fair Value and Corresponding Allowance for ECL |
Analysis of changes in the fair value and corresponding allowance for ECL by stage for debt instruments
measured at FVOCI as of December 31, 2024 and 2023, is as follows:
|
|
Stage 1 Individual |
|
|
Stage 2 Individual |
|
|
Stage 3 Individual |
|
|
Total |
|
|
|
Fair value |
|
|
ECL |
|
|
Fair value |
|
|
ECL |
|
|
Fair value |
|
|
ECL |
|
|
Fair value |
|
|
ECL |
|
|
|
MCh$ |
|
|
MCh$ |
|
|
MCh$ |
|
|
MCh$ |
|
|
MCh$ |
|
|
MCh$ |
|
|
MCh$ |
|
|
MCh$ |
|
Balance as of January 1, 2023 |
|
|
3,967,392 |
|
|
|
9,496 |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
3,967,392 |
|
|
|
9,496 |
|
Net change on Balance * |
|
|
(159,617 |
) |
|
|
(3,996 |
) |
|
|
(30,124 |
) |
|
|
(1,921 |
) |
|
|
— |
|
|
|
— |
|
|
|
(189,741 |
) |
|
|
(5,917 |
) |
Change in fair value |
|
|
8,718 |
|
|
|
— |
|
|
|
156 |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
8,874 |
|
|
|
— |
|
Transfer to Stage 1 |
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
Transfer to Stage 2 |
|
|
(29,968 |
) |
|
|
— |
|
|
|
29,968 |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
Transfer to Stage 3 |
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
Impact on year-end ECL of exposures transferred between stages during the year ** |
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
1,921 |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
1,921 |
|
Impact of net re-measurement of year-end ECL |
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
Amounts written off |
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
Foreign exchange adjustments |
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
Balance as of December 31, 2023 |
|
|
3,786,525 |
|
|
|
5,500 |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
3,786,525 |
|
|
|
5,500 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Balance as of January 1, 2024 |
|
|
3,786,525 |
|
|
|
5,500 |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
3,786,525 |
|
|
|
5,500 |
|
Net change on Balance * |
|
|
(1,694,790 |
) |
|
|
(1,274 |
) |
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
(1,694,790 |
) |
|
|
(1,274 |
) |
Change in fair value |
|
|
(3,390 |
) |
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
(3,390 |
) |
|
|
— |
|
Transfer to Stage 1 |
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
Transfer to Stage 2 |
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
Transfer to Stage 3 |
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
Impact on year-end ECL of exposures transferred between stages during the year ** |
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
Impact of net re-measurement of year-end ECL |
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
Amounts written off |
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
Foreign exchange adjustments |
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
Balance as of December 31, 2024 |
|
|
2,088,345 |
|
|
|
4,226 |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
2,088,345 |
|
|
|
4,226 |
|
* | Net change between assets purchased and assets derecognized. |
** | Represents the change in the year-end ECLs of exposures that
were transferred from one stage to another during the year. |
|
Schedule of Detail of Equity Instruments |
As of December 31, 2024 and 2023, the
detail of equity instruments is as follows:
| |
2024 | | |
2023 | |
| |
MCh$ | | |
MCh$ | |
Equity instruments issued in Chile (*) | |
| 7,277 | | |
| 10,601 | |
Equity instruments issued by foreign institutions | |
| 2,215 | | |
| 1,311 | |
Total | |
| 9,492 | | |
| 11,912 | |
| (*) | On May 3, 2024, the subsidiary Banchile Corredores de Bolsa
sold 546,278 shares of the entity. The fair value of the shares sold and the accumulated gain at the moment of disposal were Ch$2,294
and Ch$1,899 million, respectively. The result obtained has been recorded as a credit in equity accounts. |
|
Schedule of Gross Realized Gains and Losses on the Sale of Debt Financial Instruments |
Gross realized gains and losses on
the sale of debt financial instruments, as of December 31, 2024, 2023 and 2022 are reported under “Net Financial income (expense)”
(See Note No. 31). The realized gains and losses at the end of both periods are the following:
| |
2024 | | |
2023 | | |
2022 | |
| |
MCh$ | | |
MCh$ | | |
MCh$ | |
Unrealized gains (losses) | |
| 3,386 | | |
| 4,352 | | |
| (15,325 | ) |
Realized losses (gains) reclassified to income | |
| (8,050 | ) | |
| 4,522 | | |
| 63,401 | |
Subtotal | |
| (4,664 | ) | |
| 8,874 | | |
| 48,076 | |
Income tax on other comprehensive income | |
| (710 | ) | |
| (1,806 | ) | |
| 798 | |
Net effect in other comprehensive income | |
| (5,374 | ) | |
| 7,068 | | |
| 48,874 | |
|